Agios Pharmaceuticals, Inc.

Q4 2019 13F Holders

Symbol
AGIO
CUSIP
00847X104
Type
Equity
Class
COM
Num filings
223
Total reported value, excl. options
$3.29 B
Manager Report Date Value ($000) Shares Option Type